IRIS
FERRARO, GIARITA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.979
EU - Europa 2.072
NA - Nord America 1.951
SA - Sud America 437
AF - Africa 69
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 3
Totale 7.525
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.849
SG - Singapore 1.663
RU - Federazione Russa 1.056
CN - Cina 646
IT - Italia 594
BR - Brasile 353
HK - Hong Kong 246
VN - Vietnam 216
DE - Germania 112
IN - India 63
GB - Regno Unito 52
CA - Canada 46
FI - Finlandia 42
MX - Messico 42
AR - Argentina 41
KR - Corea 41
FR - Francia 40
IE - Irlanda 37
CI - Costa d'Avorio 20
SE - Svezia 20
ZA - Sudafrica 19
AT - Austria 18
NL - Olanda 18
PL - Polonia 16
ES - Italia 15
BD - Bangladesh 13
JP - Giappone 12
UA - Ucraina 12
CO - Colombia 9
ID - Indonesia 9
EC - Ecuador 8
IL - Israele 8
TR - Turchia 8
VE - Venezuela 8
AU - Australia 7
LT - Lituania 7
NZ - Nuova Zelanda 7
DZ - Algeria 6
IQ - Iraq 6
MA - Marocco 6
PY - Paraguay 6
BE - Belgio 5
CH - Svizzera 5
IR - Iran 5
PE - Perù 5
PK - Pakistan 5
AE - Emirati Arabi Uniti 4
CL - Cile 4
UZ - Uzbekistan 4
CR - Costa Rica 3
DK - Danimarca 3
EG - Egitto 3
JM - Giamaica 3
KZ - Kazakistan 3
LB - Libano 3
MY - Malesia 3
PH - Filippine 3
RO - Romania 3
RS - Serbia 3
SA - Arabia Saudita 3
SN - Senegal 3
TW - Taiwan 3
BB - Barbados 2
CZ - Repubblica Ceca 2
EE - Estonia 2
GR - Grecia 2
HT - Haiti 2
JO - Giordania 2
LU - Lussemburgo 2
OM - Oman 2
UY - Uruguay 2
AD - Andorra 1
AL - Albania 1
AO - Angola 1
BH - Bahrain 1
BO - Bolivia 1
CW - ???statistics.table.value.countryCode.CW??? 1
DJ - Gibuti 1
DM - Dominica 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
EU - Europa 1
GD - Grenada 1
GE - Georgia 1
GM - Gambi 1
KE - Kenya 1
KG - Kirghizistan 1
KH - Cambogia 1
MD - Moldavia 1
ME - Montenegro 1
ML - Mali 1
MO - Macao, regione amministrativa speciale della Cina 1
MR - Mauritania 1
MT - Malta 1
MZ - Mozambico 1
NI - Nicaragua 1
NP - Nepal 1
PS - Palestinian Territory 1
QA - Qatar 1
RE - Reunion 1
Totale 7.520
Salva come PNG Salva come JPEG
Città #
Singapore 802
Hong Kong 246
Moscow 235
Hefei 199
Ashburn 194
Chandler 194
Beijing 188
Naples 126
Napoli 114
Santa Clara 107
San Jose 99
Los Angeles 68
Ho Chi Minh City 66
Millbury 49
São Paulo 48
Boston 45
Hanoi 42
Buffalo 38
Seoul 38
New York 37
Dallas 36
Des Moines 36
Redondo Beach 32
Lawrence 31
Nanjing 29
Princeton 29
Munich 27
Dong Ket 21
The Dalles 21
Falkenstein 19
Wilmington 19
Denver 18
Mexico City 18
Rome 18
Frankfurt am Main 16
Houston 16
Florence 15
Milan 15
Orem 15
Rio de Janeiro 15
Seattle 15
Chicago 14
London 14
Ottawa 14
Amsterdam 13
Helsinki 13
Atlanta 12
Brooklyn 12
Stockholm 12
Tokyo 12
Warsaw 12
Chennai 11
Hebei 11
Da Nang 10
Manchester 10
Montreal 10
Nanchang 10
Phoenix 10
Düsseldorf 9
Kochi 9
Shenyang 9
Turku 9
Vienna 9
Fairfield 8
Johannesburg 8
Poplar 8
Toronto 8
Biên Hòa 7
Curitiba 7
Dublin 7
Mumbai 7
Padova 7
Salerno 7
Washington 7
Guangzhou 6
Haiphong 6
Jiaxing 6
Miguel Hidalgo 6
New Delhi 6
Pune 6
Querétaro 6
San Francisco 6
Wuhan 6
Marigliano 5
Poli 5
Porto Alegre 5
Thiruvarur 5
Thái Nguyên 5
Tianjin 5
Ankara 4
Boscoreale 4
Brasília 4
Brussels 4
Campinas 4
Casablanca 4
Caserta 4
Castellammare di Stabia 4
Giugliano in Campania 4
Guarulhos 4
Itaquaquecetuba 4
Totale 3.850
Salva come PNG Salva come JPEG
Nome #
C-Glycosylation in platinum-based agents: a viable strategy to improve cytotoxicity and selectivity 167
A highly efficient and selective antitumor agent based on a glucoconjugated carbene platinum(ii) complex 149
Analisi minero-petrografiche, chimiche e microbiologiche condotte sulla scultura denominata Real Infante Carlo Tito di Borbone 141
Five-Coordinate Platinum(II) Compounds Containing Sugar Ligands: Synthesis, Characterization, Cytotoxic Activity, and Interaction with Biological Macromolecules 135
Inside out Porphyridium cruentum: Beyond the Conventional Biorefinery Concept 133
Label-free quantitative proteomics of the MCF-7 cellular response to a ferritin-metallodrug complex. 131
Impact of Hydrophobic Chains in Five-Coordinate Glucoconjugate Pt(II) Anticancer Agents 129
A thermophilic C-phycocyanin with unprecedented biophysical and biochemical properties 129
Gold-based drug encapsulation within a ferritin nanocage: X-ray structure and biological evaluation as a potential anticancer agent of the Auoxo3-loaded protein 122
Mapping the protein-binding sites for iridium(III)-based CO-releasing molecules 119
A Diruthenium Metallodrug as a Potent Inhibitor of Amyloid-β Aggregation: Synergism of Mechanisms of Action 117
Five-Coordinate Platinum(II) Compounds as Potential Anticancer Agents 117
Encapsulation of the Dinuclear Trithiolato-Bridged Arene Ruthenium Complex Diruthenium-1 in an Apoferritin Nanocage: Structure and Cytotoxicity 111
Role of the Metal Center in the Modulation of the Aggregation Process of Amyloid Model Systems by Square Planar Complexes Bearing 2-(2'-pyridyl)benzimidazole Ligands 110
Protein-Based Delivery Systems for Anticancer Metallodrugs: Structure and Biological Activity of the Oxaliplatin/β-Lactoglobulin Adduct 109
A new and efficient procedure to load bioactive molecules within the human heavy-chain ferritin nanocage 108
A comparison study on RNase A oligomerization induced by cisplatin, carboplatin and oxaliplatin 108
Reaction with Proteins of a Five-Coordinate Platinum(II) Compound 108
Cisplatin binding to human serum albumin: a structural study 107
Modulation of amyloidogenic peptide aggregation by photoactivatable co-releasing ruthenium(II) complexes 107
The X-ray structure of the primary adducts formed in the reaction between cisplatin and cytochrome c. 105
Chloride-free hydrolytic sol–gel synthesis of Nb–P–Si oxides: an approach to solid acid materials 105
Effect of temperature on the interaction of cisplatin with the model protein hen egg white lysozyme 102
Preparation, structure, cytotoxicity and mechanism of action of ferritin-Pt(II) terpyridine compound nanocomposites 101
Cisplatin-Protein Interactions: Unexpected Drug Binding to N-Terminal Amine and Lysine Side Chains 100
Platinum(II) O,S Complexes Inhibit the Aggregation of Amyloid Model Systems 100
Platinated oligomers of bovine pancreatic ribonuclease: Structure and stability. 99
Caged noble metals: Encapsulation of a cytotoxic platinum(II)-gold(I) compound within the ferritin nanocage 97
Pt(II) versus Pt(IV) in Carbene Glycoconjugate Antitumor Agents: Minimal Structural Variations and Great Performance Changes 97
X-ray Structure of the Carboplatin-Loaded Apo-Ferritin Nanocage 95
Halo complexes of gold(I) containing glycoconjugate carbene ligands: synthesis, characterization, cytotoxicity and interaction with proteins and DNA model systems 94
Ferritin nanocages loaded with gold ions induce oxidative stress and apoptosis in MCF-7 human breast cancer cells 94
The non-swapped monomeric structure of the arginine-binding protein from Thermotoga maritima 92
Structural evidences for a secondary gold binding site in the hydrophobic box of lysozyme 92
Deciphering the role of neutral diruthenium complexes in protein binding 90
Cytotoxic properties of a new organometallic platinum(II) complex and its gold(i) heterobimetallic derivatives 89
Cisplatin binding to β-lactoglobulin: A structural study 89
Protein-mediated disproportionation of Au(i): insights from the structures of adducts of Au(iii) compounds bearing N,N-pyridylbenzimidazole derivatives with lysozyme 88
Dirhodium tetraacetate binding to a B-DNA double helical dodecamer probed by X-ray crystallography and mass spectrometry 87
Unusual mode of protein binding by a cytotoxic π-arene ruthenium(ii) piano-stool compound containing an O,S-chelating ligand 87
First Crystal Structure for a Gold Carbene-Protein Adduct 86
Structural Characterization of a Gold/Serum Albumin Complex 85
Unusual structural features in the adduct of dirhodium tetraacetate with lysozyme 85
Multiple and Variable Binding of Pharmacologically Active Bis(maltolato)oxidovanadium(IV) to Lysozyme 84
Platinum(II) Complexes with O,S Bidentate Ligands: Biophysical Characterization, Antiproliferative Activity, and Crystallographic Evidence of Protein Binding 84
Interaction of Platinum-based Drugs with Proteins: An Overview of Representative Crystallographic Studies 83
Interaction of VIVO-8-hydroxyquinoline species with RNase A: the effect of metal ligands in the protein adduct stabilization 82
Arsenoplatin-1 Is a Dual Pharmacophore Anticancer Agent 82
Arsenoplatin-ferritin nanocage: Structure and cytotoxicity 82
Exchange of Equatorial Ligands in Protein-bound Paddlewheel Ru25+ Complexes: New Insights form X-ray Crystallography and Quantum Chemistry 80
On the productive function of furnaces in archaeological sites 80
Ruthenium(II)-Arene Complexes with Glycosylated NHC-Carbene Co-Ligands: Synthesis, Hydrolytic Behavior, and Binding to Biological Molecules 78
Implications of Protein Interaction in the Speciation of Potential VIVO-Pyridinone Drugs 77
Structural insights and aggregation propensity of a super-stable monellin mutant: A new potential building block for protein-based nanostructured materials 76
X-ray structure of C-phycocyanin from Galdieria phlegrea: Determinants of thermostability and comparison with a C-phycocyanin in the entire phycobilisome 76
Evaluation of Auranofin Loading within Ferritin Nanocages 74
Unexpected in crystallo reactivity of the potential drug bis(maltolato)oxidovanadium(iv) with lysozyme 74
Biotic and environmental stress induces nitration and changes in structure and function of the sea urchin major yolk protein toposome 74
Bioactive Molecules Delivery through Ferritin Nanoparticles: Sum Up of Current Loading Methods 73
Protein-metallodrugs interactions: Effects on the overall protein structure and characterization of Au, Ru and Pt binding sites 73
Stabilization and Binding of [V4O12]4− and Unprecedented [V20O54(NO3)]n− to Lysozyme upon Loss of Ligands and Oxidation of the Potential Drug VIVO(acetylacetonato)2 67
Non‐Covalent and Covalent Binding of New Mixed‐Valence Cage‐like Polyoxidovanadate Clusters to Lysozyme 65
On the mechanism of action of arsenoplatins: arsenoplatin-1 binding to a B-DNA dodecamer 65
Cisplatin Binding to Human Serum Transferrin: A Crystallographic Study 62
Effect of Equatorial Ligand Substitution on the Reactivity with Proteins of Paddlewheel Diruthenium Complexes: Structural Studies 57
Cisplatin Binding Sites in Human H-Chain Ferritin 57
Ferritin-based anticancer metallodrug delivery: Crystallographic, analytical and cytotoxicity studies 56
Reactions of a tetranuclear Pt-thiosemicarbazone complex with model proteins 55
Spectroscopic/Computational Characterization and the X-ray Structure of the Adduct of the VIVO-Picolinato Complex with RNase A 55
Interactions of cisplatin analogues with lysozyme: a comparative analysis 54
Cisplatin binding to angiogenin protein: new molecular pathways and targets for the drug's anticancer activity 53
Ru-Based CO releasing molecules with azole ligands: interaction with proteins and the CO release mechanism disclosed by X-ray crystallography 53
Steric hindrance and charge influence on the cytotoxic activity and protein binding properties of diruthenium complexes 52
Exploring the interactions between model proteins and Pd(II) or Pt(II) compounds bearing charged N,N-pyridylbenzimidazole bidentate ligands by X-ray crystallography 52
A case of extensive protein platination: The reaction of lysozyme with a Pt(ii)-terpyridine complex 52
The first step of arsenoplatin-1 aggregation in solution unveiled by solving the crystal structure of its protein adduct 52
Charge effect in protein metalation reactions by diruthenium complexes 51
Platinum(ii) O,S complexes as potential metallodrugs against Cisplatin resistance 50
Principles and methods used to grow and optimize crystals of protein-metallodrug adducts, to determine metal binding sites and to assign metal ligands 50
Mitochondria Targeting with Luminescent Rhenium(I) Complexes 49
Oxaliplatin inhibits angiogenin proliferative and cell migration effects in prostate cancer cells 49
Protein interactions of dirhodium tetraacetate: a structural study 48
The NAMI A-human ferritin system: A biophysical characterization 46
Metallodrugs: Mechanisms of Action, Molecular Targets and Biological Activity 46
Structural and in Solution Studies on the Interaction of a Vanadium(V) Complex with Lysozyme 44
First Structural Evidence of Binding Modes of Decavanadate to a Protein: Insights from NMR and X-ray Crystallography 40
Reactions with proteins of three novel anticancer platinum(Ii) complexes bearing N-heterocyclic ligands 36
Cisplatin/Apo-Transferrin Adduct: X-ray Structure and Binding to the Transferrin Receptor 1 31
Metal-based carbon monoxide releasing molecules with promising cytotoxic properties 31
Binding Modes of Decavanadate to a Protein: first structural Insights from NMR, Mass Spectrometry and X-ray Crystallography 30
Binding of [VIVO(8-HQ)(H2O)]+ to the model protein lysozyme: structural and computational studies 22
Binding to Lysozyme of the Pharmacologically Active VIVO−Pyridinone Drug 21
Binding to proteins of the pharmacologically active bis(maltolato)oxidovanadium(IV) 21
Interaction of VVO2−hydrazonates with lysozyme 20
Binding to lysozyme of VIVO−pyranonato and VIVO−pyridinone 20
Speciation and structural transformation of a VV–malate complex in the absence and in the presence of a protein: from a dinuclear species to decavanadate 20
Non-covalent Interactions with Proteins of Potential Vanadium Drugs: The Case of the Lysozyme/VIVO-8-hydroxyquinoline adduct 20
V-based drug binding to RNase A 19
Interaction between lysozyme and a dioxidovanadium(V) complex of aroylhydrazone 19
Binding to the model protein lysozyme of the dioxidovanadium(V) complex of aroylhydrazone 18
Totale 7.656
Salva come PNG Salva come JPEG
Categoria #
all - tutte 24.828
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.828
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021116 0 0 0 0 0 0 7 6 19 30 16 38
2021/2022328 11 0 1 3 9 4 7 23 40 11 88 131
2022/2023465 64 33 18 22 63 53 22 59 69 11 39 12
2023/2024417 20 63 54 33 26 49 11 30 9 22 64 36
2024/20252.436 105 149 46 22 55 110 262 164 207 241 857 218
2025/20263.434 430 391 556 635 964 299 159 0 0 0 0 0
Totale 7.724